AstraZeneca plunges on promoter stake sale plans

06th March 2013 10:18 AM

AstraZeneca Pharma India, an integrated biopharmaceutical companyplunged on Wednesday after the multinational pharmaceutical company said that its promoter AstraZeneca Pharmaceuticals AB Sweden has decided to reduce its shareholding in the company to meet minimum public shareholding norm. The current shareholding of the promoter in the company is approximately 89.99%. Shares ofthe companyare trading at Rs 769.95, down Rs 63.8, or 7.65% at the Bombay Stock Exchange (BSE) on Wednesday at 9:39 a.m.The scrip has touched an intra-day high of Rs 798.45 and low of Rs 711.20. The total volume of shares traded at the BSE is 39,661.In the earlier session, the shares fell 3.38%, or Rs 29.15, at Rs 833.75. Currently, the stock is trading at all time 52-week low, which is below 70.93% over the 52-week high of Rs 2,649.

Share Price Movement Period Pricein Rs Gain/(Loss) in Rs in % 1 Week 982.50 (148.75) (15.14) 1 Month 1,340.00 (506.25) (37.78) 3 Months 1,491.05 (657.30) (44.08) 6 Months 1,785.45 (951.70) (53.30) 1 Year 2,094.15 (1,260.40) (60.19) Note: Based on previous day closing price.
A+ A A-
Post a Comment
*
1000 characters left

All comments will be reactively moderated

Disclaimer: The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. Comments are automatically posted live; however, newindianexpress.com reserves the right to take any or all comments down at any time.

Recent Activity

What's Hot?